Loading
Total declarations
Companies
▲ Purchases (9 ops.)
▼ Sales (0 ops.)
Latest filing published 19 May 2016 for Travere Therapeutics, Inc..
Insider track record
Disclosed buys
9
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
9
Positive at T+90
100%
Median T+90
+135.0%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +145.0%Entry US$8.24 · Close at T+365 US$20.19
- +82.1%Entry US$7.14 · Close at T+365 US$13.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Cornelius E. Golding: trading record in brief
Filings by Cornelius E. Golding span 4 companies, the busiest being National Atlantic Holdings Corp, Travere Therapeutics, Inc. and Neurologix Inc/de. Between 31 March 2006 and 18 May 2016, the trades on record add up to 13 filings.
No open-market sale appears; the market trades are 9 purchases worth €74k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 3 share grants.
The median purchase comes to €7,128.
Most recently, on 19 May 2016, the filings show a share grant in Travere Therapeutics, Inc. The most recent open-market purchase was published on 19 November 2014, 4,357 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Cornelius E. Golding
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
2,000 shares0Common StockSEC:0001209191-16-121506:0
20,000 sharesCommon Stock, par value $0.01/shareSEC:0001209191-15-078263:0
2,000 shares0Common StockSEC:0001209191-15-051753:0
2,000 shares@ US$9.00Common StockSEC:0001209191-14-070102:0
Canonical exit: 17 Feb 2015 (T+90)
20,000 shares0Common StockSEC:0001209191-14-067703:0
3,000 shares@ US$7.50Common StockSEC:0001193805-13-002333:0
Canonical exit: 24 Mar 2014 (T+90)
20,000 shares@ US$0.80Common StockSEC:0001193805-08-001402:0
Canonical exit: 17 Aug 2008 (T+90)
1,000 shares@ US$9.68Common StockSEC:0001209191-07-051681:0
Canonical exit: 3 Dec 2007 (T+90)
1,000 shares@ US$9.85Common StockSEC:0001209191-07-051022:0
Canonical exit: 27 Nov 2007 (T+90)
10,000 shares@ US$0.75Common StockSEC:0001304340-06-000007:0
Canonical exit: 1 Mar 2007 (T+90)
300 shares@ US$10.10Common StockSEC:0001209191-06-037753:0
Canonical exit: 29 Jun 2006 (T+90)
400 shares@ US$10.17Common StockSEC:0001209191-06-037753:1
Canonical exit: 2 Jul 2006 (T+90)
1,000 shares@ US$8.97Common StockSEC:0001209191-06-037753:2
Canonical exit: 19 Sept 2006 (T+90)
13 of 13 declarations
